VEGFA and diabetic eye disease: To test this, we prospectively assessed the need for diabetic eye disease intervention (panretinal photocoagulation (PRP), macular laser or intravitreal antivascular endothelial growth factor (VEGF) therapy) or progression/development of diabetic eye disease in a cohort of individuals commencing flash monitoring, with particular reference to achieved fall in HbA1c.